SOPs for BA-BE Studies V 2.0

To define the procedure for evaluating dilution integrity during method validation of LC-MS/MS methods for bioavailability/bioequivalence (BA/BE) studies, ensuring accurate quantification of samples above the upper limit of quantification (ULOQ) after dilution.
Click to read the full article.

To describe the procedure and controls associated with the reinjection of study samples during LC-MS/MS analysis in bioavailability/bioequivalence (BA/BE) studies, ensuring the scientific validity and integrity of reinjected data.
Click to read the full article.

To establish a structured process for managing analytical instrument breakdowns during bioanalytical phases of BA/BE studies, ensuring timely resolution, proper documentation, and continued compliance with regulatory and data integrity standards.
Click to read the full article.

To define the procedure for the planning, execution, documentation, and verification of preventive maintenance (PM) activities for analytical instruments used in BA/BE bioanalytical studies, ensuring optimal performance and regulatory compliance.
Click to read the full article.

To establish a comprehensive procedure for maintaining data integrity in all bioanalytical processes supporting bioavailability/bioequivalence (BA/BE) studies, ensuring compliance with regulatory standards and ALCOA+ principles.
Click to read the full article.

To define the procedure for systematic backup and long-term archiving of analytical data generated in bioavailability and bioequivalence (BA/BE) studies, ensuring data protection, recovery readiness, and regulatory compliance.
Click to read the full article.

To establish a standardized procedure for assessing reproducibility between multiple analytical runs conducted during bioanalytical phases of BA/BE studies, ensuring data reliability, consistency, and acceptance by regulatory authorities.
Click to read the full article.

To define a consistent and compliant process for reviewing audit trails in bioanalytical software systems to ensure transparency, traceability, and integrity of data generated during BA/BE studies.
Click to read the full article.

To describe the procedure for selection, preparation, and use of internal standards in LC-MS/MS methods used for the quantitative determination of drug concentrations in biological matrices during BA/BE studies.
Click to read the full article.

To define the procedure for qualification and monitoring of analytical column performance used in LC-MS/MS methods during BA/BE studies, ensuring consistent chromatographic behavior, reproducibility, and regulatory compliance.
Click to read the full article.